GX15-070MS
GX004
Phase 1 small_molecule completed
Quick answer
GX15-070MS for Chronic Lymphocytic Leukemia is a Phase 1 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Chronic Lymphocytic Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed